FDA Inspection 1037729 — Versari Global Health Partners, LLC
The FDA completed an inspection of Versari Global Health Partners, LLC on Dec 8, 2017 in Saint Louis, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 8, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Saint Louis, MO (United States)